Cargando…

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth

A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected in...

Descripción completa

Detalles Bibliográficos
Autores principales: Roskin, Krishna M., Jackson, Katherine J. L., Lee, Ji-Yeun, Hoh, Ramona A., Joshi, Shilpa A., Hwang, Kwan-Ki, Bonsignori, Mattia, Pedroza-Pacheco, Isabela, Liao, Hua-Xin, Moody, M. Anthony, Fire, Andrew Z., Borrow, Persephone, Haynes, Barton F., Boyd, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223457/
https://www.ncbi.nlm.nih.gov/pubmed/31959979
http://dx.doi.org/10.1038/s41590-019-0581-0
_version_ 1783533753691275264
author Roskin, Krishna M.
Jackson, Katherine J. L.
Lee, Ji-Yeun
Hoh, Ramona A.
Joshi, Shilpa A.
Hwang, Kwan-Ki
Bonsignori, Mattia
Pedroza-Pacheco, Isabela
Liao, Hua-Xin
Moody, M. Anthony
Fire, Andrew Z.
Borrow, Persephone
Haynes, Barton F.
Boyd, Scott D.
author_facet Roskin, Krishna M.
Jackson, Katherine J. L.
Lee, Ji-Yeun
Hoh, Ramona A.
Joshi, Shilpa A.
Hwang, Kwan-Ki
Bonsignori, Mattia
Pedroza-Pacheco, Isabela
Liao, Hua-Xin
Moody, M. Anthony
Fire, Andrew Z.
Borrow, Persephone
Haynes, Barton F.
Boyd, Scott D.
author_sort Roskin, Krishna M.
collection PubMed
description A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected individuals develops such antibodies, but it is unclear whether this reflects systematic differences in their antibody repertoires or is a consequence of rare stochastic events involving individual clones. We sequenced antibody heavy-chain repertoires in a large cohort of HIV-infected individuals with bNAb responses or no neutralization breadth and uninfected controls, identifying consistent features of bNAb repertoires, encompassing thousands of B cell clones per individual, with correlated T cell phenotypes. These repertoire features were not observed during chronic cytomegalovirus infection in an independent cohort. Our data indicate that the development of numerous B cell lineages with antibody features associated with autoreactivity may be a key aspect in the development of HIV neutralizing antibody breadth.
format Online
Article
Text
id pubmed-7223457
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-72234572020-05-15 Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth Roskin, Krishna M. Jackson, Katherine J. L. Lee, Ji-Yeun Hoh, Ramona A. Joshi, Shilpa A. Hwang, Kwan-Ki Bonsignori, Mattia Pedroza-Pacheco, Isabela Liao, Hua-Xin Moody, M. Anthony Fire, Andrew Z. Borrow, Persephone Haynes, Barton F. Boyd, Scott D. Nat Immunol Article A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected individuals develops such antibodies, but it is unclear whether this reflects systematic differences in their antibody repertoires or is a consequence of rare stochastic events involving individual clones. We sequenced antibody heavy-chain repertoires in a large cohort of HIV-infected individuals with bNAb responses or no neutralization breadth and uninfected controls, identifying consistent features of bNAb repertoires, encompassing thousands of B cell clones per individual, with correlated T cell phenotypes. These repertoire features were not observed during chronic cytomegalovirus infection in an independent cohort. Our data indicate that the development of numerous B cell lineages with antibody features associated with autoreactivity may be a key aspect in the development of HIV neutralizing antibody breadth. Nature Publishing Group US 2020-01-20 2020 /pmc/articles/PMC7223457/ /pubmed/31959979 http://dx.doi.org/10.1038/s41590-019-0581-0 Text en © The Author(s), under exclusive licence to Springer Nature America, Inc. 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Roskin, Krishna M.
Jackson, Katherine J. L.
Lee, Ji-Yeun
Hoh, Ramona A.
Joshi, Shilpa A.
Hwang, Kwan-Ki
Bonsignori, Mattia
Pedroza-Pacheco, Isabela
Liao, Hua-Xin
Moody, M. Anthony
Fire, Andrew Z.
Borrow, Persephone
Haynes, Barton F.
Boyd, Scott D.
Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
title Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
title_full Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
title_fullStr Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
title_full_unstemmed Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
title_short Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
title_sort aberrant b cell repertoire selection associated with hiv neutralizing antibody breadth
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223457/
https://www.ncbi.nlm.nih.gov/pubmed/31959979
http://dx.doi.org/10.1038/s41590-019-0581-0
work_keys_str_mv AT roskinkrishnam aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT jacksonkatherinejl aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT leejiyeun aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT hohramonaa aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT joshishilpaa aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT hwangkwanki aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT bonsignorimattia aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT pedrozapachecoisabela aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT liaohuaxin aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT moodymanthony aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT fireandrewz aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT borrowpersephone aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT haynesbartonf aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth
AT boydscottd aberrantbcellrepertoireselectionassociatedwithhivneutralizingantibodybreadth